Akorn (AKRX) has risen sharply, recording gains of 2.98% in the past 4 weeks. However, the stock has corrected -6.71% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 3.54% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
The stock has recorded a 20-day Moving Average of 1.28% and the 50-Day Moving Average is 7.35%.The 200 Day SMA reached 4.05%
Akorn (NASDAQ:AKRX): After opening at $26.83, the stock dipped to an intraday low of $26.45 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $27.52 and the buying power remained strong till the end. The stock closed at $27.26 for the day, a gain of 2.33% for the day session. The total traded volume was 1,063,268. The stocks close on the previous trading day was $27.26.
Akorn (AKRX) : Currently there are 8 street experts covering Akorn (AKRX) stock. The most bullish and bearish price target for the stock is $40 and $31 respectively for the short term. The average price target of all the analysts comes to $35.88. The estimated standard deviation from the target is $3.23.
Akorn Inc. (Akorn), together with its wholly owned subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as animal and over-the-counter (OTC) consumer health products. The Company specializes in sterile and non-sterile dosage forms, including ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays. The Company operates in two segments: Prescription Pharmaceuticals, which is engaged in the sale of branded and generic prescription pharmaceuticals, and Consumer Health, which is engaged in the sale of branded and private label consumer and animal health products. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York, and Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, and an additional warehousing facility in Amityville, New York.